eli lilly lawsuit tirzepatide Mounjaro - July 2026 Update Eli Lilly Files Slew of

The FDA approval process involves a series of stringent steps to ensure the safety and efficacy of new drugs

Company: Novo-Nordisk Merilog (insulin aspart-szjj) Injection Approval Date: February 2025 Indication: Diabetes Mellitus Why It Matters: As a biosimilar to NovoLog (insulin aspart), Merilog provides a cost-effective, rapid-acting insulin option for both adult and pediatric patients with diabetes mellitus

Convenience This is where drops win

Because while many products are marketed as peptides for fat loss or peptides for muscle gain, only one category has strong clinical evidence for weight loss: GLP-1 receptor agonists

Individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or known allergies to any component of Tirzepatide are not candidates for this therapy